Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bioharvest Sciences (BHST) Research & Development (2023 - 2025)

Bioharvest Sciences has reported Research & Development over the past 3 years, most recently at $1.3 million for Q4 2025.

  • For Q4 2025, Research & Development fell 7.09% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $5.3 million, up 10.74%, while the annual FY2025 figure was $5.3 million, 10.74% up from the prior year.
  • Research & Development was $1.3 million for Q4 2025 at Bioharvest Sciences, down from $1.4 million in the prior quarter.
  • Across five years, Research & Development topped out at $1.4 million in Q3 2025 and bottomed at $812000.0 in Q2 2023.
  • The 3-year median for Research & Development is $1.2 million (2025), against an average of $1.2 million.
  • Year-over-year, Research & Development skyrocketed 42.95% in 2024 and then dropped 7.09% in 2025.
  • Over 3 years, Research & Development stood at $1.1 million in 2023, then skyrocketed by 32.79% to $1.4 million in 2024, then fell by 7.09% to $1.3 million in 2025.
  • The last three reported values for Research & Development were $1.3 million (Q4 2025), $1.4 million (Q3 2025), and $1.3 million (Q2 2025) per Business Quant data.